ADCs	Antibody-drug conjugates
ALCL	Anaplastic large-cell lymphoma
AML	Acute myelogenous leukemia
BCMA	B-cell maturation antigen
CA9	Carbonic anhydrase IX
CEA	Carcinoembryonic antigen
CLL	Chronic lymphocytic leukemia
DAR	Drug-to-antibody ratio
DLBCL	Diffuse large B cell lymphoma
DTT	Dithiothreitol
EDNRB	Endothelin receptor type B
EGFR	Epidermal growth factor receptor
ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3
EphA2	Ephrin type-A receptor 2
EphB2	Ephrin type-B receptor 2
FDA	Food and Drug Administration
GCC	Guanyl cyclase C
GPNMB	Transmembrane glycoprotein NMB
GTP	Guanosine triphosphate
HER2	Human epidermal growth factor receptor 2
HL	Hodgkin’s lymphoma
IgG	Immunoglobulin G
LBCL	Large B-cell lymphoma
LY6E	Lymphocyte antigen 6 complex
mAb	Monoclonal antibody
MBC	Metastatic breast cancer
MC	Maleimidocaproyl
MCC	4-(N-Maleimidomethyl)cyclohexane-1-carboxylate
MDR	Multiple-drug resistant
MDR1	Multidrug resistance protein 1
MM	Multiple myeloma
MMAE	Monomethyl auristatin E
MMAF	Monomethyl auristatin F
MTD	Maximum tolerated dose
MUC16	Mucin 16
NHL	Non-Hodgkin’s lymphoma
NSCLC	Non-small cell lung cancer
PEG	Polyethylene glycol
PK/PD	Pharmacokinetic/pharmacodynamics
PSMA	Prostate specific membrane antigen
RCC	Renal cell carcinoma
SAR	Structure-activity relationship
SCLC	Small-cell lung cancer
SLITRK6	SLIT and NTRK-like protein 6
SMCC	Succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate
SPDB	N-Succinimidyl-4-(2-pyridyldithio)butanoate
SPP	N-Succinimidyl 4-(2-pyridyldithio) pentanoate
sSPDB	Sulfo-SPDB
STEAP1	Six transmembrane epithelial Antigen of prostate 1
TAG-72	Tumor-associated glycoprotein-72
vc	Valine-citrulline